LIPID-ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODS
The invention provides, inter alia, improved lipid formulations used to generate lipid-encapsulated gas microspheres, and methods of their use.
1 . A composition comprising
a non-aqueous mixture comprising DPPA, DPPC and PEG5000-DPPE in propylene glycol, or propylene glycol and glycerol, or glycerol, and
a perfluorocarbon gas.
2 - 27 . (canceled)
28 . The composition of claim 1 , wherein the composition is provided in a single chamber container.
29 . The composition of claim 1 , wherein the composition is provided in a multiple chamber container.
30 . A container comprising the composition of claim 1 .
31 . The container of claim 30 , wherein the container is a single chamber container.
32 . The container of claim 30 , wherein the container comprises a first and a second chamber, and wherein the non-aqueous mixture is in the first chamber and the perfluorocarbon gas is in the second chamber.
33 . A container comprising the composition of claim 1 in a first chamber, and propylene glycol or glycerol or propylene glycol and glycerol in a second chamber.
34 . A container comprising the composition of claim 1 in a first chamber and an aqueous diluent in a second chamber.
35 . The container of claim 34 , wherein the aqueous diluent is an aqueous saline solution.
36 . The container of claim 34 , wherein the aqueous diluent is an aqueous buffered saline solution.
37 - 38 . (canceled)
39 . A composition comprising
a mixture of DPPA, DPPC and PEG5000-DPPE in solid form, and
a perfluorocarbon gas.
40 . A container comprising the composition of claim 39 .
41 . The container of claim 40 , having a single chamber.
42 . The container of claim 40 , having a first chamber, wherein the composition is present in the first chamber of the container.
43 . The container of claim 40 , having two chambers, wherein a first chamber comprises DPPA, DPPC and PEG5000-DPPE in solid form, and a second chamber comprises the perfluorocarbon gas.
44 - 49 . (canceled)
50 . A composition comprising
lipid-encapsulated gas microspheres comprising DPPA, DPPC and PEG5000-DPPE and perfluorocarbon gas, in a non-aqueous solution comprising propylene glycol and glycerol.
51 - 87 . (canceled)
88 . A method of forming an ultrasound contrast agent comprising
adding glycerol and/or an aqueous diluent to the composition of claim 1 , and
then activating the composition to form lipid-encapsulated gas microspheres.
89 - 99 . (canceled)